AKEBIA THERAPEUTICS, INC. Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments
AKEBIA THERAPEUTICS, INC. (AKBA) had Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments of $7.00 thousand as of 2017-09-30, per its 10-Q filed 2017-11-08.
Discontinued › Notes › Leases
us-gaap:CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments · last filed 2017-11-08
- 2017-09-30: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $7.00K.
- 2017-06-30: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $9.00K.
- 2017-03-31: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $11.00K.
- 2016-12-31: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $14.00K.
| Period end | Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments |
|---|---|
| 2017-09-30 | $7.00K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $9.00K 10-Q · filed 2017-08-08 |
| 2017-03-31 | $11.00K 10-Q · filed 2017-05-09 |
| 2016-12-31 | $14.00K 10-K · filed 2017-03-06 |
| 2016-09-30 | $17.00K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $19.00K 10-Q · filed 2016-08-08 |
| 2016-03-31 | $22.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | $14.00K 10-K · filed 2016-03-14 |
| 2015-09-30 | $16.00K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $18.00K 10-Q · filed 2015-08-11 |
| 2015-03-31 | $19.00K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $8.35K 10-K · filed 2015-03-04 |
| 2014-09-30 | $9.33K 10-Q · filed 2014-11-10 |
| 2014-06-30 | $10.31K 10-Q · filed 2014-08-11 |
| 2014-03-31 | $11.28K 10-Q · filed 2014-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |